Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (45)

« Back to Publications

Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health Interventions.

Koleva-Kolarova R. et al, (2026), Appl Health Econ Health Policy

Roux-en-Y gastric bypass, adjustable gastric banding or sleeve gastrectomy for severe obesity: The By-Band-Sleeve randomised controlled trial.

(2026), Health Technol Assess, 30, 1 - 224

The HERC Database of Mapping Studies: a 2025 update of a live systematic review of studies predicting EQ-5D from other patient-reported outcome measures

Mallon K. et al, (2025), Value in Health, 28, s534 - s535

Q-squared as a mapping model performance metric in gastrointestinal disease

Mallon K. et al, (2025), Value in Health, 28

HERC database of mapping studies, Version 10.0

DAKIN H. et al, (2025)

Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity: the By-Band-Sleeve multi-centre, open label, three-group randomised controlled trial

POUWELS K. et al, (2025), The Lancet Diabetes and Endocrinology

Genetic-Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations.

Lim KK. et al, (2024), J Am Heart Assoc, 13

A protocol for mobilising novel finance models for collaborative health promotion and disease prevention initiatives: taking a smart capacitating investment approach in the Invest4Health project.

Lane J. et al, (2024), Front Public Health, 12

HERC database of mapping studies, Version 9.0

DAKIN H. et al, (2023)

Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.

Liao W. et al, (2023), Lancet Respir Med, 11, 685 - 697

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in three health systems.

Koleva-Kolarova R. et al, (2023), Per Med, 20, 357 - 374

Cost-effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK.

Koleva-Kolarova R. et al, (2023), Per Med, 20, 339 - 355

Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries.

Szilberhorn L. et al, (2023), Per Med, 20, 387 - 399

Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementation.

Koleva-Kolarova R. et al, (2023), Per Med, 20, 305 - 319

Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young.

Kovács G. et al, (2023), Per Med, 20, 375 - 385

Load More